Vonoprazan (Potassium-Competitive Acid Blocker)

Type: drug

Status: FDA Approved (in combination for H. pylori)

Developer: Takeda Pharmaceutical Company

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026